Barriers to new drug development in respiratory disease.

Brigden, Grania; du Cros, Philipp; Wong, Sidney

Brigden, Grania; du Cros, Philipp; Wong, Sidney.

Affiliation

Brigden G; Médecins Sans Frontières, Geneva, Switzerland graniabrigden@doctors.org.uk.
du Cros P; Médecins Sans Frontières, London, UK.
Wong S; Médecins Sans Frontières, Operational Centre Amsterdam, Amsterdam, The Netherlands.

Eur Respir J ; 47(1): 356-7, 2016 Jan.

Article in En | MEDLINE | ID: mdl-26721975

Subject(s)

Antitubercular Agents/therapeutic use; Drug Discovery; Extensively Drug-Resistant Tuberculosis/drug therapy; Awards and Prizes; Diarylquinolines/therapeutic use; Humans; Motivation; Nitroimidazoles/therapeutic use; Oxazoles/therapeutic use; Tuberculosis, Multidrug-Resistant/drug therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Extensively Drug-Resistant Tuberculosis / Drug Discovery / Antitubercular Agents Limits: Humans Language: En Journal: Eur Respir J Year: 2016 Document type: Article Affiliation country: Switzerland Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google